Global Preventive Vaccines Market Growth 2024-2030
The global Preventive Vaccines market, valued at US$ 53,370 million in 2023, is projected to expand with rising demand for vaccines aimed at preventing a variety of diseases.
- Bonafide Trust
- 20-09-2024
- Pages : 99
- Figures : 82
- Tables : 108
- Region : Global
- Category : Lifescience & Healthcare
- Pharmaceutical
The global preventive vaccine market encompasses a diverse range of biological preparations designed to stimulate the immune system and provide protection against infectious diseases. These vaccines play a pivotal role in public health, significantly reducing morbidity and mortality rates worldwide. The market encompasses a wide spectrum of vaccines, including those targeting bacterial infections like pneumococcal disease and meningitis, viral infections such as influenza, measles, mumps, rubella, and human papillomavirus (HPV), as well as those combating life-threatening illnesses like polio, hepatitis, and tetanus. Technological advancements in vaccine development have led to the emergence of innovative platforms, such as mRNA vaccines, which have demonstrated remarkable efficacy in recent years, particularly in the context of the COVID-19 pandemic. These novel technologies offer the potential for rapid response to emerging infectious diseases and personalized vaccine approaches. The global preventive vaccines market is driven by several key factors, including increasing government initiatives for immunization programs, rising prevalence of infectious diseases, growing awareness about the importance of vaccination, and substantial investments in research and development by both the public and private sectors. Furthermore, the expanding geriatric population, which is more susceptible to vaccine-preventable diseases, is expected to fuel market growth. The market also faces certain challenges, such as vaccine hesitancy and misinformation, limited access to vaccines in low- and middle-income countries, and the emergence of vaccine-resistant strains of pathogens. Addressing these challenges requires a multi-pronged approach, including robust public health education campaigns, equitable vaccine distribution strategies, and continuous surveillance and research to develop effective countermeasures against emerging threats. The global preventive vaccines market is poised for significant growth in the coming years, driven by ongoing innovation, expanding immunization coverage, and a renewed focus on global health security. Continued advancements in vaccine technology, coupled with a concerted effort to overcome existing challenges, will be crucial in ensuring that vaccines remain a cornerstone of global public health strategies and continue to save countless lives.
According to Publisher, the global Preventive Vaccines market size was valued at US$ 53370 million in 2023. With growing demand in downstream market, the Preventive Vaccines is forecast to a readjusted size of US$ 96940 million by 2030 with a CAGR of 8.9% during review period. The research report highlights the growth potential of the global Preventive Vaccines market. Preventive Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Preventive Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Preventive Vaccines market. Preventive vaccines are targeted at healthy populations and are available to susceptible populations.It refers to the preventive vaccination of the patient before the infection of the pathogen or in the body without the disease. The report on Preventive Vaccines market reflects various aspects and provide valuable insights into the industry. The research report provide an overview of the current size and growth of the Preventive Vaccines market. It may include historical data, market segmentation by Type (e.g., Intramuscular Injection, Nasal Spray), and regional breakdowns. The research report provides analysis of the competitive landscape within the Preventive Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market. Technological Developments: The research report can delve into the latest technological developments in the Preventive Vaccines industry. This include advancements in Preventive Vaccines technology, Preventive Vaccines new entrants, Preventive Vaccines new investment, and other innovations that are shaping the future of Preventive Vaccines. The report can shed light on customer procumbent behaviour and adoption trends in the Preventive Vaccines market.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleThe global preventive vaccines market is segmented based on the type of vaccine technology employed. Live attenuated vaccines, which utilize weakened forms of the pathogen to trigger an immune response, currently dominate the market. These vaccines offer robust and long-lasting immunity, making them highly effective against a wide range of diseases such as measles, mumps, rubella, and polio. Inactivated vaccines, which contain killed or inactivated forms of the pathogen, are another significant segment. These vaccines are generally considered safer than live attenuated vaccines, as they cannot replicate in the body. However, they may require multiple doses to achieve optimal immunity. Subunit vaccines, which contain only specific parts of the pathogen, such as proteins or polysaccharides, offer a targeted immune response while minimizing the risk of adverse reactions. Conjugate vaccines, a type of subunit vaccine, are particularly effective against bacterial infections by improving the immune response in young children. Other vaccine types, such as toxoid vaccines (using inactivated toxins), recombinant vaccines (using genetically engineered components), and DNA vaccines (using genetic material), are also available and continue to evolve, offering promising avenues for future vaccine development.
The global preventive vaccine market is segmented based on their application, encompassing a wide range of infectious diseases. Vaccines targeting viral infections, such as influenza, measles, mumps, rubella, human papillomavirus (HPV), and more recently, COVID-19, constitute a significant portion of the market. These vaccines have demonstrated remarkable success in controlling the spread of highly contagious diseases and reducing associated morbidity and mortality. Bacterial infections, including pneumococcal disease, meningitis, diphtheria, tetanus, and pertussis, also represent a major segment. Vaccines against these infections, such as pneumococcal conjugate vaccines and diphtheria-tetanus-pertussis (DTP) vaccines, are crucial for protecting infants and young children from life-threatening illnesses. Other significant applications include vaccines against parasitic diseases like malaria and helminthiasis, which are prevalent in endemic regions. The market also encompasses vaccines for emerging and re-emerging infectious diseases, highlighting the dynamic nature of vaccine development in response to evolving public health challenges.
The global preventive vaccines market exhibits diverse regional dynamics. North America and Europe currently dominate the market, driven by robust healthcare infrastructure, high vaccination rates, and significant investments in research and development. These regions boast advanced healthcare systems with well-established immunization programs, facilitating widespread access to vaccines. However, the Asia-Pacific region is projected to witness the fastest growth due to factors such as increasing population, rising disposable incomes, growing awareness about the importance of vaccination, and expanding government initiatives to improve immunization coverage. The Latin American, Middle Eastern, and African regions also present significant growth opportunities, albeit with varying levels of healthcare infrastructure and access to vaccines. Overcoming challenges such as vaccine hesitancy, limited access in underserved populations, and the emergence of vaccine-resistant strains will be crucial for ensuring equitable access and maximizing the impact of vaccines across all regions.
Table of Contents
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Preventive Vaccines Annual Sales 2019-2030
- 2.1.2 World Current & Future Analysis for Preventive Vaccines by Geographic Region, 2019, 2023 & 2030
- 2.1.3 World Current & Future Analysis for Preventive Vaccines by Country/Region, 2019, 2023 & 2030
- 2.2 Preventive Vaccines Segment by Type
- 2.2.1 Intramuscular Injection
- 2.2.2 Nasal Spray
- 2.2.3 Intradermal Shot
- 2.3 Preventive Vaccines Sales by Type
- 2.3.1 Global Preventive Vaccines Sales Market Share by Type (2019-2024)
- 2.3.2 Global Preventive Vaccines Revenue and Market Share by Type (2019-2024)
- 2.3.3 Global Preventive Vaccines Sale Price by Type (2019-2024)
- 2.4 Preventive Vaccines Segment by Application
- 2.4.1 Hospital
- 2.4.2 Clinic
- 2.4.3 Other
- 2.5 Preventive Vaccines Sales by Application
- 2.5.1 Global Preventive Vaccines Sale Market Share by Application (2019-2024)
- 2.5.2 Global Preventive Vaccines Revenue and Market Share by Application (2019-2024)
- 2.5.3 Global Preventive Vaccines Sale Price by Application (2019-2024)
- 3 Global Preventive Vaccines by Company
- 3.1 Global Preventive Vaccines Breakdown Data by Company
- 3.1.1 Global Preventive Vaccines Annual Sales by Company (2019-2024)
- 3.1.2 Global Preventive Vaccines Sales Market Share by Company (2019-2024)
- 3.2 Global Preventive Vaccines Annual Revenue by Company (2019-2024)
- 3.2.1 Global Preventive Vaccines Revenue by Company (2019-2024)
- 3.2.2 Global Preventive Vaccines Revenue Market Share by Company (2019-2024)
- 3.3 Global Preventive Vaccines Sale Price by Company
- 3.4 Key Manufacturers Preventive Vaccines Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Preventive Vaccines Product Location Distribution
- 3.4.2 Players Preventive Vaccines Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
- 4 World Historic Review for Preventive Vaccines by Geographic Region
- 4.1 World Historic Preventive Vaccines Market Size by Geographic Region (2019-2024)
- 4.1.1 Global Preventive Vaccines Annual Sales by Geographic Region (2019-2024)
- 4.1.2 Global Preventive Vaccines Annual Revenue by Geographic Region (2019-2024)
- 4.2 World Historic Preventive Vaccines Market Size by Country/Region (2019-2024)
- 4.2.1 Global Preventive Vaccines Annual Sales by Country/Region (2019-2024)
- 4.2.2 Global Preventive Vaccines Annual Revenue by Country/Region (2019-2024)
- 4.3 Americas Preventive Vaccines Sales Growth
- 4.4 APAC Preventive Vaccines Sales Growth
- 4.5 Europe Preventive Vaccines Sales Growth
- 4.6 Middle East & Africa Preventive Vaccines Sales Growth
- 5 Americas
- 5.1 Americas Preventive Vaccines Sales by Country
- 5.1.1 Americas Preventive Vaccines Sales by Country (2019-2024)
- 5.1.2 Americas Preventive Vaccines Revenue by Country (2019-2024)
- 5.2 Americas Preventive Vaccines Sales by Type
- 5.3 Americas Preventive Vaccines Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Preventive Vaccines Sales by Region
- 6.1.1 APAC Preventive Vaccines Sales by Region (2019-2024)
- 6.1.2 APAC Preventive Vaccines Revenue by Region (2019-2024)
- 6.2 APAC Preventive Vaccines Sales by Type
- 6.3 APAC Preventive Vaccines Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
- 7 Europe
- 7.1 Europe Preventive Vaccines by Country
- 7.1.1 Europe Preventive Vaccines Sales by Country (2019-2024)
- 7.1.2 Europe Preventive Vaccines Revenue by Country (2019-2024)
- 7.2 Europe Preventive Vaccines Sales by Type
- 7.3 Europe Preventive Vaccines Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Preventive Vaccines by Country
- 8.1.1 Middle East & Africa Preventive Vaccines Sales by Country (2019-2024)
- 8.1.2 Middle East & Africa Preventive Vaccines Revenue by Country (2019-2024)
- 8.2 Middle East & Africa Preventive Vaccines Sales by Type
- 8.3 Middle East & Africa Preventive Vaccines Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Preventive Vaccines
- 10.3 Manufacturing Process Analysis of Preventive Vaccines
- 10.4 Industry Chain Structure of Preventive Vaccines
- 11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Preventive Vaccines Distributors
- 11.3 Preventive Vaccines Customer
- 12 World Forecast Review for Preventive Vaccines by Geographic Region
- 12.1 Global Preventive Vaccines Market Size Forecast by Region
- 12.1.1 Global Preventive Vaccines Forecast by Region (2025-2030)
- 12.1.2 Global Preventive Vaccines Annual Revenue Forecast by Region (2025-2030)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Preventive Vaccines Forecast by Type
- 12.7 Global Preventive Vaccines Forecast by Application
- 13 Key Players Analysis
- 13.1 Sanofi
- 13.1.1 Sanofi Company Information
- 13.1.2 Sanofi Preventive Vaccines Product Portfolios and Specifications
- 13.1.3 Sanofi Preventive Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.1.4 Sanofi Main Business Overview
- 13.1.5 Sanofi Latest Developments
- 13.2 AstraZeneca
- 13.2.1 AstraZeneca Company Information
- 13.2.2 AstraZeneca Preventive Vaccines Product Portfolios and Specifications
- 13.2.3 AstraZeneca Preventive Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.2.4 AstraZeneca Main Business Overview
- 13.2.5 AstraZeneca Latest Developments
- 13.3 CSL Ltd
- 13.3.1 CSL Ltd Company Information
- 13.3.2 CSL Ltd Preventive Vaccines Product Portfolios and Specifications
- 13.3.3 CSL Ltd Preventive Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.3.4 CSL Ltd Main Business Overview
- 13.3.5 CSL Ltd Latest Developments
- 13.4 Abbott
- 13.4.1 Abbott Company Information
- 13.4.2 Abbott Preventive Vaccines Product Portfolios and Specifications
- 13.4.3 Abbott Preventive Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.4.4 Abbott Main Business Overview
- 13.4.5 Abbott Latest Developments
- 13.5 GlaxoSmithKline
- 13.5.1 GlaxoSmithKline Company Information
- 13.5.2 GlaxoSmithKline Preventive Vaccines Product Portfolios and Specifications
- 13.5.3 GlaxoSmithKline Preventive Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.5.4 GlaxoSmithKline Main Business Overview
- 13.5.5 GlaxoSmithKline Latest Developments
- 13.6 Serum Institute of India
- 13.6.1 Serum Institute of India Company Information
- 13.6.2 Serum Institute of India Preventive Vaccines Product Portfolios and Specifications
- 13.6.3 Serum Institute of India Preventive Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.6.4 Serum Institute of India Main Business Overview
- 13.6.5 Serum Institute of India Latest Developments
- 14 Research Findings and Conclusion
Table 1. Preventive Vaccines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Preventive Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Intramuscular Injection
Table 4. Major Players of Nasal Spray
Table 5. Major Players of Intradermal Shot
Table 6. Global Preventive Vaccines Sales by Type (2019-2024) & (K Doses)
Table 7. Global Preventive Vaccines Sales Market Share by Type (2019-2024)
Table 8. Global Preventive Vaccines Revenue by Type (2019-2024) & ($ million)
Table 9. Global Preventive Vaccines Revenue Market Share by Type (2019-2024)
Table 10. Global Preventive Vaccines Sale Price by Type (2019-2024) & (USD/Doses)
Table 11. Global Preventive Vaccines Sales by Application (2019-2024) & (K Doses)
Table 12. Global Preventive Vaccines Sales Market Share by Application (2019-2024)
Table 13. Global Preventive Vaccines Revenue by Application (2019-2024)
Table 14. Global Preventive Vaccines Revenue Market Share by Application (2019-2024)
Table 15. Global Preventive Vaccines Sale Price by Application (2019-2024) & (USD/Doses)
Table 16. Global Preventive Vaccines Sales by Company (2019-2024) & (K Doses)
Table 17. Global Preventive Vaccines Sales Market Share by Company (2019-2024)
Table 18. Global Preventive Vaccines Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Preventive Vaccines Revenue Market Share by Company (2019-2024)
Table 20. Global Preventive Vaccines Sale Price by Company (2019-2024) & (USD/Doses)
Table 21. Key Manufacturers Preventive Vaccines Producing Area Distribution and Sales Area
Table 22. Players Preventive Vaccines Products Offered
Table 23. Preventive Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Preventive Vaccines Sales by Geographic Region (2019-2024) & (K Doses)
Table 27. Global Preventive Vaccines Sales Market Share Geographic Region (2019-2024)
Table 28. Global Preventive Vaccines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Preventive Vaccines Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Preventive Vaccines Sales by Country/Region (2019-2024) & (K Doses)
Table 31. Global Preventive Vaccines Sales Market Share by Country/Region (2019-2024)
Table 32. Global Preventive Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Preventive Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Preventive Vaccines Sales by Country (2019-2024) & (K Doses)
Table 35. Americas Preventive Vaccines Sales Market Share by Country (2019-2024)
Table 36. Americas Preventive Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Preventive Vaccines Revenue Market Share by Country (2019-2024)
Table 38. Americas Preventive Vaccines Sales by Type (2019-2024) & (K Doses)
Table 39. Americas Preventive Vaccines Sales by Application (2019-2024) & (K Doses)
Table 40. APAC Preventive Vaccines Sales by Region (2019-2024) & (K Doses)
Table 41. APAC Preventive Vaccines Sales Market Share by Region (2019-2024)
Table 42. APAC Preventive Vaccines Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Preventive Vaccines Revenue Market Share by Region (2019-2024)
Table 44. APAC Preventive Vaccines Sales by Type (2019-2024) & (K Doses)
Table 45. APAC Preventive Vaccines Sales by Application (2019-2024) & (K Doses)
Table 46. Europe Preventive Vaccines Sales by Country (2019-2024) & (K Doses)
Table 47. Europe Preventive Vaccines Sales Market Share by Country (2019-2024)
Table 48. Europe Preventive Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Preventive Vaccines Revenue Market Share by Country (2019-2024)
Table 50. Europe Preventive Vaccines Sales by Type (2019-2024) & (K Doses)
Table 51. Europe Preventive Vaccines Sales by Application (2019-2024) & (K Doses)
Table 52. Middle East & Africa Preventive Vaccines Sales by Country (2019-2024) & (K Doses)
Table 53. Middle East & Africa Preventive Vaccines Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Preventive Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Preventive Vaccines Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Preventive Vaccines Sales by Type (2019-2024) & (K Doses)
Table 57. Middle East & Africa Preventive Vaccines Sales by Application (2019-2024) & (K Doses)
Table 58. Key Market Drivers & Growth Opportunities of Preventive Vaccines
Table 59. Key Market Challenges & Risks of Preventive Vaccines
Table 60. Key Industry Trends of Preventive Vaccines
Table 61. Preventive Vaccines Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Preventive Vaccines Distributors List
Table 64. Preventive Vaccines Customer List
Table 65. Global Preventive Vaccines Sales Forecast by Region (2025-2030) & (K Doses)
Table 66. Global Preventive Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Preventive Vaccines Sales Forecast by Country (2025-2030) & (K Doses)
Table 68. Americas Preventive Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Preventive Vaccines Sales Forecast by Region (2025-2030) & (K Doses)
Table 70. APAC Preventive Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Preventive Vaccines Sales Forecast by Country (2025-2030) & (K Doses)
Table 72. Europe Preventive Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Preventive Vaccines Sales Forecast by Country (2025-2030) & (K Doses)
Table 74. Middle East & Africa Preventive Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Preventive Vaccines Sales Forecast by Type (2025-2030) & (K Doses)
Table 76. Global Preventive Vaccines Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Preventive Vaccines Sales Forecast by Application (2025-2030) & (K Doses)
Table 78. Global Preventive Vaccines Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Sanofi Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 80. Sanofi Preventive Vaccines Product Portfolios and Specifications
Table 81. Sanofi Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 82. Sanofi Main Business
Table 83. Sanofi Latest Developments
Table 84. AstraZeneca Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 85. AstraZeneca Preventive Vaccines Product Portfolios and Specifications
Table 86. AstraZeneca Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 87. AstraZeneca Main Business
Table 88. AstraZeneca Latest Developments
Table 89. CSL Ltd Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 90. CSL Ltd Preventive Vaccines Product Portfolios and Specifications
Table 91. CSL Ltd Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 92. CSL Ltd Main Business
Table 93. CSL Ltd Latest Developments
Table 94. Abbott Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. Abbott Preventive Vaccines Product Portfolios and Specifications
Table 96. Abbott Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 97. Abbott Main Business
Table 98. Abbott Latest Developments
Table 99. GlaxoSmithKline Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. GlaxoSmithKline Preventive Vaccines Product Portfolios and Specifications
Table 101. GlaxoSmithKline Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 102. GlaxoSmithKline Main Business
Table 103. GlaxoSmithKline Latest Developments
Table 104. Serum Institute of India Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. Serum Institute of India Preventive Vaccines Product Portfolios and Specifications
Table 106. Serum Institute of India Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 107. Serum Institute of India Main Business
Table 108. Serum Institute of India Latest Developments
List of
Figure 1. Picture of Preventive Vaccines
Figure 2. Preventive Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Preventive Vaccines Sales Growth Rate 2019-2030 (K Doses)
Figure 7. Global Preventive Vaccines Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Preventive Vaccines Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Intramuscular Injection
Figure 10. Product Picture of Nasal Spray
Figure 11. Product Picture of Intradermal Shot
Figure 12. Global Preventive Vaccines Sales Market Share by Type in 2023
Figure 13. Global Preventive Vaccines Revenue Market Share by Type (2019-2024)
Figure 14. Preventive Vaccines Consumed in Hospital
Figure 15. Global Preventive Vaccines Market: Hospital (2019-2024) & (K Doses)
Figure 16. Preventive Vaccines Consumed in Clinic
Figure 17. Global Preventive Vaccines Market: Clinic (2019-2024) & (K Doses)
Figure 18. Preventive Vaccines Consumed in Other
Figure 19. Global Preventive Vaccines Market: Other (2019-2024) & (K Doses)
Figure 20. Global Preventive Vaccines Sales Market Share by Application (2023)
Figure 21. Global Preventive Vaccines Revenue Market Share by Application in 2023
Figure 22. Preventive Vaccines Sales Market by Company in 2023 (K Doses)
Figure 23. Global Preventive Vaccines Sales Market Share by Company in 2023
Figure 24. Preventive Vaccines Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Preventive Vaccines Revenue Market Share by Company in 2023
Figure 26. Global Preventive Vaccines Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Preventive Vaccines Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Preventive Vaccines Sales 2019-2024 (K Doses)
Figure 29. Americas Preventive Vaccines Revenue 2019-2024 ($ Millions)
Figure 30. APAC Preventive Vaccines Sales 2019-2024 (K Doses)
Figure 31. APAC Preventive Vaccines Revenue 2019-2024 ($ Millions)
Figure 32. Europe Preventive Vaccines Sales 2019-2024 (K Doses)
Figure 33. Europe Preventive Vaccines Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Preventive Vaccines Sales 2019-2024 (K Doses)
Figure 35. Middle East & Africa Preventive Vaccines Revenue 2019-2024 ($ Millions)
Figure 36. Americas Preventive Vaccines Sales Market Share by Country in 2023
Figure 37. Americas Preventive Vaccines Revenue Market Share by Country in 2023
Figure 38. Americas Preventive Vaccines Sales Market Share by Type (2019-2024)
Figure 39. Americas Preventive Vaccines Sales Market Share by Application (2019-2024)
Figure 40. United States Preventive Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Preventive Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Preventive Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Preventive Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Preventive Vaccines Sales Market Share by Region in 2023
Figure 45. APAC Preventive Vaccines Revenue Market Share by Regions in 2023
Figure 46. APAC Preventive Vaccines Sales Market Share by Type (2019-2024)
Figure 47. APAC Preventive Vaccines Sales Market Share by Application (2019-2024)
Figure 48. China Preventive Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Preventive Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Preventive Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Preventive Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Preventive Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Preventive Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Preventive Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Preventive Vaccines Sales Market Share by Country in 2023
Figure 56. Europe Preventive Vaccines Revenue Market Share by Country in 2023
Figure 57. Europe Preventive Vaccines Sales Market Share by Type (2019-2024)
Figure 58. Europe Preventive Vaccines Sales Market Share by Application (2019-2024)
Figure 59. Germany Preventive Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Preventive Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Preventive Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Preventive Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Preventive Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Preventive Vaccines Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Preventive Vaccines Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Preventive Vaccines Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Preventive Vaccines Sales Market Share by Application (2019-2024)
Figure 68. Egypt Preventive Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Preventive Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Preventive Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Preventive Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Preventive Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Preventive Vaccines in 2023
Figure 74. Manufacturing Process Analysis of Preventive Vaccines
Figure 75. Industry Chain Structure of Preventive Vaccines
Figure 76. Channels of Distribution
Figure 77. Global Preventive Vaccines Sales Market Forecast by Region (2025-2030)
Figure 78. Global Preventive Vaccines Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Preventive Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Preventive Vaccines Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Preventive Vaccines Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Preventive Vaccines Revenue Market Share Forecast by Application (2025-2030)
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (09 May, 2026)
- Notify To Team (09 May, 2026)
- Report updation (10 May, 2026)
- Report Quality Check (10 May, 2026)
- Report Dispatch (11 May, 2026)
- Hard Copy
Recently Viewed Products
Global Preventive Vaccines Market Growth 2024-2030
We are friendly and approachable, give us a call.